BEONE MEDICINES LTD. Cash and Cash Equivalents, Period Increase (Decrease)
BEONE MEDICINES LTD. (ONC) reported Cash and Cash Equivalents, Period Increase (Decrease) of $152.09 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-28
- BEONE MEDICINES LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $31.09M, a 1468.72% increase year-over-year.
- BEONE MEDICINES LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$52.50M, a 291.26% decline year-over-year.
- BEONE MEDICINES LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $163.26M.
- BEONE MEDICINES LTD. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $10.24M, a 94.63% decline year-over-year.
- BEONE MEDICINES LTD. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $152.09M, a 118.38% increase from fiscal 2016.
- BEONE MEDICINES LTD. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $69.64M, a 1653.84% increase from fiscal 2015.
- BEONE MEDICINES LTD. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $3.97M, a 60.18% decline from fiscal 2014.
- BEONE MEDICINES LTD. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $9.97M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $31.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$21.40M derived: sum of 2 quarters · filed 2018-02-28 | $141.85M derived: sum of 3 quarters · filed 2018-02-28 | $152.09M 10-K · filed 2018-02-28 |
| 2017-09-30 | -$52.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $110.76M derived: sum of 2 quarters · filed 2017-11-13 | $121.00M 10-Q · filed 2017-11-13 | $122.98M derived: sum of 4 quarters · filed 2018-02-28 |
| 2017-06-30 | $163.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $173.49M 10-Q · filed 2017-08-09 | $175.47M derived: sum of 3 quarters · filed 2018-02-28 | $202.92M derived: sum of 4 quarters · filed 2018-02-28 |
| 2017-03-31 | $10.24M 10-Q · filed 2017-05-10 | $12.22M derived: sum of 2 quarters · filed 2018-02-28 | $39.67M derived: sum of 3 quarters · filed 2018-02-28 | -$110.76M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $29.43M derived: sum of 2 quarters · filed 2018-02-28 | -$120.99M derived: sum of 3 quarters · filed 2018-02-28 | $69.64M 10-K · filed 2018-02-28 |
| 2016-09-30 | $27.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$122.97M derived: sum of 2 quarters · filed 2017-11-13 | $67.66M 10-Q · filed 2017-11-13 | $58.08M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$150.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $40.22M 10-Q · filed 2017-08-09 | $30.63M derived: sum of 3 quarters · filed 2018-02-28 | $32.93M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $190.64M 10-Q · filed 2017-05-10 | $181.06M derived: sum of 2 quarters · filed 2018-02-28 | $183.35M derived: sum of 3 quarters · filed 2018-02-28 | $195.14M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | -$9.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$7.29M derived: sum of 2 quarters · filed 2018-02-28 | $4.50M derived: sum of 3 quarters · filed 2018-02-28 | $3.97M 10-K · filed 2018-02-28 |
| 2015-09-30 | $2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $14.08M derived: sum of 2 quarters · filed 2016-11-10 | $13.55M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $11.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $11.26M 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | -$531.00K 10-Q · filed 2016-05-12 | |||
| 2014-12-31 | $9.97M 10-K · filed 2017-03-22 |